These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines. Bandrick M, Gutiérrez AH, Desai P, Rincon G, Martin WD, Terry FE, De Groot AS, Foss DL. Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900 [Abstract] [Full Text] [Related]
25. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Opriessnig T, O'Neill K, Gerber PF, de Castro AM, Gimenéz-Lirola LG, Beach NM, Zhou L, Meng XJ, Wang C, Halbur PG. Vaccine; 2013 Jan 07; 31(3):487-94. PubMed ID: 23174198 [Abstract] [Full Text] [Related]
26. A nanobody-horseradish peroxidase fusion protein-based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2. Mu Y, Jia C, Zheng X, Zhu H, Zhang X, Xu H, Liu B, Zhao Q, Zhou EM. J Nanobiotechnology; 2021 Feb 01; 19(1):34. PubMed ID: 33526021 [Abstract] [Full Text] [Related]
27. Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology. Karuppannan AK, Opriessnig T. Viruses; 2017 May 06; 9(5):. PubMed ID: 28481275 [Abstract] [Full Text] [Related]
28. Comparison of the immunoperoxidase monolayer assay and three commercial ELISAs for detection of antibodies against porcine circovirus type 2. Pileri E, Cortey M, Rodríguez F, Sibila M, Fraile L, Segalés J. Vet J; 2014 Sep 06; 201(3):429-32. PubMed ID: 24928421 [Abstract] [Full Text] [Related]
29. Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2. Meng T, Jia Q, Liu S, Karuppannan AK, Chang CC, Kwang J. J Virol Methods; 2010 May 06; 165(2):222-9. PubMed ID: 20152863 [Abstract] [Full Text] [Related]
30. In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. Zhou JY, Shang SB, Gong H, Chen QX, Wu JX, Shen HG, Chen TF, Guo JQ. J Biotechnol; 2005 Aug 04; 118(2):201-11. PubMed ID: 15964652 [Abstract] [Full Text] [Related]
31. Comparison of pathogenicity of 4 porcine circovirus type 2 (PCV2) genotypes (2a, 2b, 2d, and 2e) in experimentally infected pigs. Cho H, Oh T, Suh J, Chae C. J Vet Med Sci; 2023 Jan 12; 85(1):83-87. PubMed ID: 36418063 [Abstract] [Full Text] [Related]
32. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger SR, Meng XJ. Vaccine; 2014 Jul 23; 32(34):4342-8. PubMed ID: 24929119 [Abstract] [Full Text] [Related]
34. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. Walker IW, Konoby CA, Jewhurst VA, McNair I, McNeilly F, Meehan BM, Cottrell TS, Ellis JA, Allan GM. J Vet Diagn Invest; 2000 Sep 23; 12(5):400-5. PubMed ID: 11021425 [Abstract] [Full Text] [Related]
35. Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China. Liu C, Liu Y, Chen H, Feng H, Chen Y, Wang Y, Wang J, Liu D, Deng R, Zhang G. Arch Virol; 2018 Apr 23; 163(4):937-946. PubMed ID: 29305646 [Abstract] [Full Text] [Related]
37. Development of gold Immunochromatographic assay strip based on specific polyclonal antibodies against capsid protein for rapid detection of porcine circovirus 2 in Zhejiang province, China. Ding H, Shen Y, Gao Y, Wu S, Xie C, Sun H, Zhang H, Sun H, Shan Y, Ding J, Zheng B, Lu S, Zhuo X. BMC Vet Res; 2022 Oct 18; 18(1):373. PubMed ID: 36253821 [Abstract] [Full Text] [Related]